References
1 Results from the 2004 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H–27, DHHS Publication No. SMA 05–4061). Rockville, MD, 2004. NSDUH is an annual survey conducted by the Substance Abuse and Mental Health Services Administration. Copies of the latest survey are available from the National Clearinghouse for Alcohol and Drug Information at 800-729-6686.
2 These data are from the annual Drug Abuse Warning Network, funded by the Substance Abuse and Mental Health Services Administration, DHHS. The survey provides information about emergency department visits that are induced by or related to the use of an illicit drug or the non-medical use of a legal drug. The latest data are available at 800-729-6686 or online at www.samhsa.gov.
3 These data are from the 2005 Monitoring the Future Survey, funded by the National Institute on Drug Abuse, National Institutes of Health, DHHS, and conducted annually by the University of Michigan’s Institute for Social Research. The survey has tracked 12th-graders’ illicit drug use and related attitudes since 1975; in 1991, 8th- and 10th-graders were added to the study. The latest data are online at www.drugabuse.gov.
4 Herkenham M, Lynn A, Little MD, Johnson MR, et al. Cannabinoid receptor localization in the brain. Proc Natl Acad Sci, USA 87(5):1932–1936, 1990.
5 Rodriguez de Fonseca F, et al. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276(5321):2050–2054, 1997.
6 Diana M, Melis M, Muntoni AL, et al. Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc Natl Acad Sci 95(17):10269–10273, 1998.
7 Mittleman MA, Lewis RA, Maclure M, et al. Triggering myocardial infarction by marijuana. Circulation 103(23):2805–2809, 2001.
8 Polen MR, Sidney S, Tekawa IS, et al. Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med 158(6):596–601, 1993.
9 Tashkin DP. Pulmonary complications of smoked substance abuse. West J Med 152(5):525–530, 1990.
10 Zhang ZF, Morgenstern H, Spitz MR, et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiology, Biomarkers & Prevention 8(12):1071–1078, 1999.
11 Sridhar KS, Raub WA, Weatherby, NL Jr., et al. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. Journal of Psychoactive Drugs 26(3):285–288, 1994.
12 Hoffman D, Brunnemann KD, Gori GB, et al. On the carcinogenicity of marijuana smoke. In: VC Runeckles, ed, Recent Advances in Phytochemistry. New York. Plenum, 1975.
13 Cohen S. Adverse effects of marijuana: Selected issues. Annals of the New York Academy of Sciences 362:119–124, 1981.
14 Adams IB, Martin BR: Cannabis: pharmacology and toxicology in animals and humans. Addiction 91(11):1585–1614, 1996.
15 Friedman H, Newton C, Klein TW. Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 16(2):209–219, 2003.
16 Zhu LX, Sharma M, Stolina S, et al. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunology 165(1):373–380, 2000.
17 Brook JS, Rosen Z, Brook DW. The effect of early marijuana use on later anxiety and depressive symptoms. NYS Psychologist 35–39, January 2001.
18 Brook JS, Cohen P, Brook DW. Longitudinal study of co-occurring psychiatric disorders and substance use. J Acad Child and Adolescent Psych 37(3):322–330, 1998.
19 Pope HG, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA 275(7):521–527, 1996.
20 Block RI, Ghoneim MM. Effects of chronic marijuana use on human cognition. Psychopharmacology 100(1–2):219–228, 1993.
21 Lynskey M, Hall W. The effects of adolescent cannabis use on educational attainment: A review. Addiction 95(11):1621–1630, 2000.
22 Kandel DB, Davies M. High school students who use crack and other drugs. Arch Gen Psychiatry 53(1):71–80, 1996.
23 Rob M, Reynolds I, Finlayson PF. Adolescent marijuana use: Risk factors and implications. Aust NZ J Psychiatry 24(1):45–56, 1990.
24 Brook JS, Balka EB, Whiteman M. The risks for late adolescence of early adolescent marijuana use. Am J Public Health 89(10):1549–1554, 1999.
25 Pope HG, Gruber AJ, Hudson JI, et al. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 58(10):909–915, 2001.
26 Zwerling C, Ryan J, Orav EJ. The efficacy of pre-employment drug screening for marijuana and cocaine in predicting employment outcome. JAMA 264(20):2639–2643, 1990.
27 Gruber AJ, Pope HG, Hudson JI, et al. Attributes of long-term heavy cannabis users: A case control study. Psychological Medicine 33(8):1415–1422, 2003.
28 Fried PA, Makin JE. Neonatal behavioural correlates of prenatal exposure to marihuana, cigarettes and alcohol in a low risk population. Neurotoxicology and Teratology 9(1):1–7, 1987.
29 Lester BM, Dreher M. Effects of marijuana use during pregnancy on newborn crying. Child Development 60(23/24):764–771, 1989.
30 Fried PA. The Ottawa prenatal prospective study (OPPS): Methodological issues and findings. It’s easy to throw the baby out with the bath water. Life Sciences 56(23–24):2159–2168, 1995. 31 Fried PA, Smith AM. A literature review of the consequences of prenatal marihuana exposure: An emerging theme of a deficiency in aspects of executive function. Neurotoxicology and Teratology 23(1):1–11, 2001.
32 Kouri EM, Pope HG, Lukas SE. Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology 143(3):302–308, 1999.
33 Haney M, Ward AS, Comer SD, et al. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology 141(4):395–404, 1999.
34 Lyons MJ, Toomey R, Meyer JM, et al. How do genes influence marijuana use? The role of subjective effects. Addiction 92(4):409–417, 1997.
35 These data from the Treatment Episode Data Set (TEDS) 2003: Substance Abuse Treatment Admissions by Primary Substance of Abuse, According to Sex, Age Group, Race, and Ethnicity, funded by the Substance Abuse and Mental Health Services Administration, DHHS. The latest data are available at 800-729-6686 or online at www.samhsa.gov.
36 Stephens RS, Roffman RA, Curtin L. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol 68(5):898–908, 2000.
37 Budney AJ, Higgins ST, Radonovich KJ, et al. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 68(6):1051–1061, 2000. * Article Source: National Institute on Drug Abuse; http://www.drugabuse.gov/infofacts/marijuana.html